Has Jiangsu Xinda Biopharmaceutical Company entered clinical medicine?

Jiangsu Xinda biopharmaceutical company has entered clinical medicine, and has made certain achievements in drug research and development, clinical trials and production in many fields. Official website information of Jiangsu Xinda biopharmaceutical company shows that the company has successfully carried out clinical trials of various drugs, and some drugs have been registered and approved at home and abroad. Specifically, Jiangsu Xinda Bio-pharmaceutical Company has completed the clinical research of various drugs for cancer, diabetes, hepatitis B, influenza and other diseases, and has carried out related industrial production. For example, Jiangsu Xinda Biopharmaceutical Company's recombinant human heparin for injection and recombinant human hemoglobin for injection have obtained domestic drug registration approval and started industrial production. In addition, Jiangsu Xinda Biopharmaceutical Company is still developing a number of new drugs, including innovative drugs for tumors, cardiovascular diseases and nervous system diseases.